by | Apr 22, 2026 | News
Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds created by university researchers with the potential to transform pain management and address the opioid epidemic. The compound can be used to... 
by | Apr 21, 2026 | News
Young children are more inclined to believe incorrect math information from men than accurate information from women, according to a Rutgers University–New Brunswick study published in the journal Developmental Science. The findings suggest that early gender... by | Apr 21, 2026 | News
Addressing Mental Illness and Addiction among Individuals with Intellectual and Developmental Disabilities Elizabeth M. Stone, MD MSPH, Rutgers Robert Wood Johnson Medical School This presentation will provide an overview of the current evidence on prevalence and... by | Apr 20, 2026 | News
How Obesity Therapeutics Are Influencing the Pharmaceutical Industry, and Other Current Topics in Drug Development The day will include talks by experts in the field, followed by Q&A. Breakfast, lunch, coffee break and refreshments will be provided. Introductory... 
by | Apr 20, 2026 | News
Researchers at Rutgers Robert Wood Johnson Medical School in New Brunswick are enrolling participants in the National Alzheimer’s Disease Cooperative Study, which seeks to determine whether benfotiamine, a synthetic form of thiamine (vitamin B1), can help slow... 